Robert Andrew Douglas Resmed Inc (RSMDF) insider trading activity

Robert Andrew Douglas is Special Advisor of RESMED INC. Currently has a direct ownership of 13,849 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Nov 20, 2023, when has been sold 1,375 shares (ResMed Common Stock) at a price of $148.94 per share, resulting in proceeds of $204,792. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.8K

0% 3M change

74.14% 12M change

Total Value Held $0

Robert Andrew Douglas Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2023	SELL Payment of exercise price or tax liability	$204,792 $148.94 p/Share	1,375 Reduced 9.03%	13,849 ResMed Common Stock
Nov 13 2023	SELL Payment of exercise price or tax liability	$244,550 $143.6 p/Share	1,703 Reduced 10.06%	15,224 ResMed Common Stock
Nov 23 2022	SELL Payment of exercise price or tax liability	$4,358,970 $224.4 p/Share	19,425 Reduced 26.62%	53,556 ResMed Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	32,795 Added 31.0%	72,981 ResMed Common Stock
Nov 15 2022	SELL Open market or private sale	$2,504,949 $222.07 p/Share	11,280 Reduced 21.92%	40,186 ResMed Common Stock
Nov 15 2022	BUY Exercise of conversion of derivative security	$1,050,183 $58.24 p/Share	18,032 Added 25.95%	51,466 ResMed Common Stock
Nov 11 2022	SELL Payment of exercise price or tax liability	$383,931 $225.18 p/Share	1,705 Reduced 4.85%	33,434 ResMed Common Stock

Oct 14 2022	SELL Open market or private sale	$2,442,347 $215.09 p/Share	11,355 Reduced 24.45%	35,086 ResMed Common Stock
Oct 14 2022	BUY Exercise of conversion of derivative security	$1,050,242 $58.24 p/Share	18,033 Added 27.97%	46,441 ResMed Common Stock
Sep 15 2022	SELL Open market or private sale	$2,601,554 $232.51 p/Share	11,189 Reduced 28.26%	28,408 ResMed Common Stock
Sep 15 2022	BUY Exercise of conversion of derivative security	$1,050,242 $58.24 p/Share	18,033 Added 31.29%	39,597 ResMed Common Stock
Aug 18 2022	BUY Grant, award, or other acquisition	-	4,328 Added 16.72%	21,564 ResMed Common Stock
Apr 18 2022	SELL Open market or private sale	$1,866,320 $233.29 p/Share	8,000 Reduced 31.78%	17,175 ResMed Common Stock
Apr 18 2022	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 24.11%	25,175 ResMed Common Stock
Mar 15 2022	SELL Open market or private sale	$1,904,560 $238.07 p/Share	8,000 Reduced 31.78%	17,175 ResMed Common Stock
Mar 15 2022	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 24.11%	25,175 ResMed Common Stock
Feb 15 2022	SELL Open market or private sale	$1,886,480 $235.81 p/Share	8,000 Reduced 31.78%	17,175 ResMed Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 24.11%	25,175 ResMed Common Stock
Jan 18 2022	SELL Open market or private sale	$1,982,400 $247.8 p/Share	8,000 Reduced 31.78%	17,175 ResMed Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 24.11%	25,175 ResMed Common Stock
Dec 15 2021	SELL Open market or private sale	$2,052,160 $256.52 p/Share	8,000 Reduced 31.78%	17,175 ResMed Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 24.11%	25,175 ResMed Common Stock
Nov 18 2021	BUY Grant, award, or other acquisition	-	2,612 Added 5.78%	42,554 ResMed Common Stock
Nov 17 2021	SELL Payment of exercise price or tax liability	$6,914,269 $254.81 p/Share	27,135 Reduced 40.45%	39,942 ResMed Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	$11,673,101 $254.81 p/Share	45,811 Added 40.58%	67,077 ResMed Common Stock

Also insider at

GMED

GLOBUS MEDICAL INC Healthcare

RAD